1 |
Przysucha N, Górska K, Krenke R. Chitinases and Chitinase-Like Proteins in Obstructive Lung Diseases - Current Concepts and Potential Applications. Int J Chron Obstruct Pulmon Dis 2020;15:885-99. [PMID: 32368034 DOI: 10.2147/COPD.S236640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
2 |
Topcu DB, Tugcu G, Er B, Polat SE, Hizal M, Yalcin EE, Ersoz DD, Coplu L, Ozcelik U, Kiper N, Lay I, Oztas Y. Increased Plasma YKL-40 Level and Chitotriosidase Activity in Cystic Fibrosis Patients. Inflammation 2021. [PMID: 34637032 DOI: 10.1007/s10753-021-01572-2] [Reference Citation Analysis]
|
3 |
Perez MF, Atuegwu NC, Mortensen EM, Oncken C. The inflammatory biomarker YKL-40 is elevated in the serum, but not the sputum, of E-cigarette users. Exp Lung Res 2021;47:55-66. [PMID: 33200966 DOI: 10.1080/01902148.2020.1847216] [Reference Citation Analysis]
|
4 |
Harlander M, Lestan D, Turel M. Chitotriosidase Activity in Plasma and COPD Exacerbations. Lung 2020;198:299-306. [PMID: 31982942 DOI: 10.1007/s00408-020-00331-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Oishi K, Matsunaga K, Shirai T, Hirai K, Gon Y. Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease. J Clin Med 2020;9:E2670. [PMID: 32824775 DOI: 10.3390/jcm9082670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|